ClinicalTrials.gg
Enrolling by invitationNCT04893278Updated Jan 21, 2026

Virtual Reality in Electrophysiology Laboratory (EP)

An observational study in PVC - Premature Ventricular Complex and Ablation, sponsored by Mayo Clinic. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-21.

Sponsored by Mayo Clinic · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
10
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the use of virtual reality (VR) technology as adjunct to routine anesthesia care for patients undergoing electrophysiology (EP) procedures.

02

Conditions studied

  • PVC - Premature Ventricular Complex
  • Ablation

Keywords

  • virtual reality
03

In context

Ventricular Premature Complexes

102 studies on the registry are indexed under Ventricular Premature Complexes; 32 are open to participants now.

This study's planned enrollment of 10 is below the median of 125 across 39 observational studies indexed under Ventricular Premature Complexes.

Browse Ventricular Premature Complexes studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,269 studies on the registry; 672 are open to participants now.

Of its 452 completed or terminated interventional studies of FDA-regulated products, 321 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects will be selected from patients undergoing procedures under monitored anesthesia care.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years old.
  • Patients scheduled for electrophysiology procedure with MAC.
  • Subject willing to participate and able to provide .

Exclusion criteria

Exclusion Criteria:

  • Age \< 18 years old.
  • History of motion sickness or blindness.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
10 participants (estimated)
Patient registry
No

Groups and cohorts

  • Virtual reality

    Other: Virtual reality

Interventions

  • OtherVirtual reality

    Use of Virtual reality goggles during procedure

06

What researchers measure

Primary outcomes

  1. Virtual reality as distractor

    Evaluate patients' experience and satisfaction with using virutal reality during electrophysiology procedures

    Time frame: Up to 2hours

Secondary outcomes

  1. Impact of virtual reality use on pharmacological therapy

    Evalute the amount of medications use during the procedure

    Time frame: Up to 2 hours

  2. Impact of virtual reality on electrophysilogy procedure

    Evaluate success rate of completing ablation while patient is utilizing virtual reality

    Time frame: Up to 2 hours

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04893278
Lead sponsor
Mayo Clinic
Responsible party
Klaus D. Torp (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
May 19, 2021
Start date
Jul 31, 2021
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jan 21, 2026

Study contacts

Klaus Torp, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion